1. Market Research
  2. > Evocutis PLC – Product Pipeline Review – 2013

Evocutis PLC – Product Pipeline Review – 2013

  • April 2013
  • -
  • Global Markets Direct
  • -
  • 44 pages

Evocutis PLC – Product Pipeline Review – 2013

Summary

Global Market Direct’s pharmaceuticals report, “Evocutis PLC - Product Pipeline Review - 2013” provides data on the Evocutis PLC’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Evocutis PLC’s corporate website, SEC filings, investor presentations and featured press releases, both from Evocutis PLC and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- Evocutis PLC - Brief Evocutis PLC overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Evocutis PLC human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Evocutis PLC with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Evocutis PLC’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Evocutis PLC’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Evocutis PLC in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Evocutis PLC’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Evocutis PLC.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Evocutis PLC and identify potential opportunities in those areas.

Table Of Contents

Evocutis PLC - Product Pipeline Review - 2013
Table of Contents

Table of Contents 2
List of Tables 4
List of Figures 4
Evocutis PLC Snapshot 5
Evocutis PLC Overview 5
Key Information 5
Key Facts 5
Evocutis PLC - Research and Development Overview 6
Key Therapeutic Areas 6
Evocutis PLC - Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products - Monotherapy 9
Pipeline Products - Combination Treatment Modalities 10
Evocutis PLC - Pipeline Products Glance 11
Evocutis PLC - Early Stage Pipeline Products 11
Pre-Clinical Products/Combination Treatment Modalities 11
Discovery Products/Combination Treatment Modalities 12
Evocutis PLC - Drug Profiles 13
delmopinol 13
Product Description 13
Mechanism of Action 13
RandD Progress 13
Emollient-1 14
Product Description 14
Mechanism of Action 14
RandD Progress 14
Emollient-2 15
Product Description 15
Mechanism of Action 15
RandD Progress 15
Emollient-3 16
Product Description 16
Mechanism of Action 16
RandD Progress 16
SYN-0017 17
Product Description 17
Mechanism of Action 17
RandD Progress 17
SYN-0051 18
Product Description 18
Mechanism of Action 18
RandD Progress 18
SYN-0096 19
Product Description 19
Mechanism of Action 19
RandD Progress 19
SYN-0693 + SYN-0117 20
Product Description 20
Mechanism of Action 20
RandD Progress 20
SYN-0854 21
Product Description 21
Mechanism of Action 21
RandD Progress 21
SYN-1039 22
Product Description 22
Mechanism of Action 22
RandD Progress 22
SYN-1113 23
Product Description 23
Mechanism of Action 23
RandD Progress 23
Evocutis PLC - Pipeline Analysis 24
Evocutis PLC - Pipeline Products by Therapeutic Class 24
Evocutis PLC - Pipeline Products by Route of Administration 25
Evocutis PLC - Recent Pipeline Updates 26
Evocutis PLC - Dormant Projects 27
Evocutis PLC - Company Statement 28
Evocutis PLC - Locations And Subsidiaries 30
Head Office 30
Other Locations and Subsidiaries 30
Financial Deals Landscape 31
Evocutis PLC, Deals Summary 31
Evocutis PLC, Pharmaceuticals and Healthcare, Deal Details 32
Partnerships 32
Syntopix Enters Into Research Agreement With Beiersdorf 32
Syntopix Enters Into Co-Development Agreement With Sinclair Pharma 33
Syntopix Group Enters Into Co-Development Agreement With The Procter and Gamble 34
Equity Offering 35
Evocutis Completes Private Placement Of $3 Million 35
Syntopix Completes Private Placement Of $3 Million 37
Syntopix Completes Private Placement Of $3 Million 39
Acquisition 41
Evocutis Completes Acquisition Of Leeds Skin Centre For $2 Million 41
Appendix 43
Methodology 43
Coverage 43
Secondary Research 43
Primary Research 43
Expert Panel Validation 43
Contact Us 44
Disclaimer 44



List of Tables

Evocutis PLC, Key Information 5
Evocutis PLC, Key Facts 5
Evocutis PLC - Pipeline by Indication, 2013 7
Evocutis PLC - Pipeline by Stage of Development, 2013 8
Evocutis PLC - Monotherapy Products in Pipeline, 2013 9
Evocutis PLC - Combination Treatment Modalities in Pipeline, 2013 10
Evocutis PLC - Pre-Clinical, 2013 11
Evocutis PLC - Discovery, 2013 12
Evocutis PLC - Pipeline By Therapeutic Class, 2013 24
Evocutis PLC - Pipeline By Route of Administration, 2013 25
Evocutis PLC - Recent Pipeline Updates, 2013 26
Evocutis PLC - Dormant Developmental Projects,2013 27
Evocutis PLC, Subsidiaries 30
Evocutis PLC, Deals Summary 31
Syntopix Enters Into Research Agreement With Beiersdorf 32
Syntopix Enters Into Co-Development Agreement With Sinclair Pharma 33
Syntopix Group Enters Into Co-Development Agreement With The Procter and Gamble 34
Evocutis Completes Private Placement Of $3 Million 35
Syntopix Completes Private Placement Of $3 Million 37
Syntopix Completes Private Placement Of $3 Million 39
Evocutis Completes Acquisition Of Leeds Skin Centre For $2 Million 41



List of Figures

Evocutis PLC - Pipeline by Indication, 2013 7
Evocutis PLC - Pipeline by Stage of Development, 2013 8
Evocutis PLC - Monotherapy Products in Pipeline, 2013 9
Evocutis PLC - Combination Treatment Modalities in Pipeline, 2013 10
Evocutis PLC - Pipeline By Therapeutic Class, 2013 24
Evocutis PLC - Pipeline By Route of Administration, 2013 25

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

ref:plp2013

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.